| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5c24684033fba97d1ad845ce453a57e3 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7023
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-635
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L15-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-402
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-635
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-10 |
| filingDate |
1987-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b495bbf94db1ee0c872a2485ef1d6cc2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_11bcb54db32091b44d665a8f02f9c1a4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff691153ad72610fb1733e15fd586bb7 |
| publicationDate |
1987-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0247507-A2 |
| titleOfInvention |
Composition for transdermal therapeutical systems of high-ceiling diuretics, and process for producing it |
| abstract |
A composition for transdermal therapeutic systems is described which contains furosemide, piretanide or lemidosul as an active ingredient or a physiologically acceptable salt of these loop diuretics in a base consisting of a fatty acid alkanolamide or a fatty acid alkanolamide mixture with 8-18 carbon atoms in the fatty acid residue and 2 to 6 carbon atoms and 1 to Contains 3 hydroxyl groups in the alkanolamide radical and optionally a carboxylic acid ester or a carboxylic acid ester mixture each having 1-22 carbon atoms in the carboxylic acid part and 1-22 carbon atoms in the alcohol part. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0802782-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0802782-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007026124-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-10223932-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007026124-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0331092-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03099271-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0331092-A3 |
| priorityDate |
1986-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |